Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan ○
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.